What is the clinical character of Fitz-Hugh-Curtis syndrome?

Dec 23, 2008

Fitz-Hugh-Curtis syndrome is characterized by inflammation in perihepatic capsules with concomitant pelvic inflammation. The pain in the right upper abdomen appeared as the main symptom. These cases have to be cautiously differentiated from diseases for which the major symptom is pain in the right upper abdomen Fitz-Hugh-Curtis syndrome has been classified as a benign disease that can be diagnosed by non-invasive methoids and treated readily by antibiotic therapy. Nevertheless, without sufficient understanding of this disease, it could be misdiagnosed as other acute diseases with similar clinical symptoms, and thus patients may undergo unnecessary treatment or tests.

A research article to be published on December 7, 2008 in the World Journal of Gastroenterology addresses this question. The research team led by Jin Il Kim from the Catholic University of Korea analyzed the clinical characteristics of patients diagnosed with Fitz-Hugh-Curtis syndrome.

Fitz-Hugh-Curtis syndrome was identified in 22 female patients of childbearing age; their mean age was 31.0 ± 8.1 years. Fourteen of these cases presented with pain in the upper right abdomen alone or together with pain in the lower abdomen, and 6 patients presented with pain only in the lower abdomen. The first impression at the time of visit was acute cholecystitis or cholangitis in 10 patients and acute appendicitis or a pelvic inflammatory disease in 8 patients. Twenty-one patients were diagnosed by abdominal CT, and the results of abdominal sonography were normal for 10 of the patients. C. trichomatis was isolated from 18 patients, and except 2 patients performed laparoscopic adhesiotomy, 20 patients were completely cured by antibiotics treatment.

They concluded that for childbearing-age women with acute pain in the upper right abdomen alone or together with pain in the lower abdomen and that have normal liver function test results, Fitz-Hugh-Curtis syndrome should be differentiated-diagnosed. Moreover, for the cases suspected to be Fitz-Hugh-Curtis syndrome, abdominal CT, rather than abdominal sonography, assists in the diagnosis.

Source: World Journal of Gastroenterology

Explore further: 'Ebola will return', veteran scientist warns

Related Stories

Research seeks to make robotic 'human patient simulators'

Apr 08, 2015

A young doctor leans over a patient who has been in a serious car accident and invariably must be experiencing pain. The doctor's trauma team examines the patient's pelvis and rolls her onto her side to check ...

New technology reduces size of spinal stimulator implants

Nov 20, 2014

Spinal cord stimulator implants could use less power and be made much smaller as work from Taiwan and Israel eliminates off-chip high-voltage devices from the implant's pulse generator. This will reduce implant-related ...

Giffords awake, communicates after skull surgery

May 19, 2011

(AP) -- A day after surgery to repair her skull, Arizona Rep. Gabrielle Giffords' doctor has dubbed her "gorgeous Gabby," encouraged by how she looks and is communicating after an operation considered a major ...

Recommended for you

'Ebola will return', veteran scientist warns

8 hours ago

Congolese expert Jean-Jacques Muyembe may be little known to the public, but he has been one of the world's top Ebola investigators since the first epidemic erupted in central Africa in 1976.

Score IDs patients with upper extremity DVT at low risk

23 hours ago

(HealthDay)—For patients with upper-extremity deep vein thrombosis (DVT), six easily available factors can be used to create a score that identifies those at low risk of adverse events during the first ...

Combined drug treatment combats kidney disease

May 29, 2015

A recent discovery by drug researchers whereby coupling specific cell membrane receptors has altered kidney cell function has triggered a re-think of how to treat chronic kidney disease (CKD) more effectively.

Active substance targeting dreaded hospital germs

May 29, 2015

In the German Center for Infection Research (DZIF), scientists have conducted clinical studies on an active substance against the dreaded hospital pathogen Staphylococcus aureus: a highly effective protein from bacteriophages ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.